Expert Review of Neurotherapeutics

Article	Citations
Compassion focused therapy: a systematic review of its effectiveness and acceptability in clinical populations	86
Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease	49
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system	48
Therapeutic advances in Dravet syndrome: a targeted literature review	43
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives	42
Manganese-induced neurodegenerative diseases and possible therapeutic approaches	34
Update on diagnosis in disorders of consciousness	33
Clinical diagnosis and management of small fiber neuropathy: an update on best practice	31
Diagnosing and managing post-stroke aphasia	29
The emerging role of psilocybin and MDMA in the treatment of mental illness	29
Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice	29
Noninvasive brain stimulation combined with exercise in chronic pain: a systematic review and meta-analysis	28
Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy	27
The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders	26
A systematic review of morbidities suggestive of the multiple sclerosis prodrome	26
Nutrition-based interventions for mood disorders	24
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies	24
Sex differences in schizophrenia relevant to clinical care	23
Prevention of sudden unexpected death in epilepsy: current status and future perspectives	22
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults	22
What is the potential of neurostimulation in the treatment of motor symptoms in schizophrenia?	22
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis	22
Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes	22
Role of environmental factors in multiple sclerosis	22
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome	21

Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review	21
Gene therapy for Parkinson’s disease: contemporary practice and emerging concepts	20
Cannabis and multiple sclerosis	20
Focal cortical dysplasia: an update on diagnosis and treatment	20
Emerging therapies in Friedreich’s Ataxia	20
Clinical development of valbenazine for tics associated with Tourette syndrome	20
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease	19
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs	19
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management	18
Motor imagery and gait control in Parkinson’s disease: techniques and new perspectives in neurorehabilitation	18
Robot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges	18
Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone	17
Sensory stimulation programs in dementia: a systematic review of methods and effectiveness	17
mHealth for pediatric chronic pain: state of the art and future directions	17
Medication overuse headache: an overview of clinical aspects, mechanisms, and treatments	17
Efficacy and safety of greater occipital nerve block for the treatment of cluster headache: a systematic review and meta-analysis	17
Combination therapy in migraine: asset or issue?	16
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems	16
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies	16
Psychotherapy in recurrent depression: efficacy, pitfalls, and recommendations	16
The effect of physical activity with and without cognitive demand on the improvement of executive functions and behavioral symptoms in children with ADHD	16
Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms	16
Acute ischemic stroke management: concepts and controversies.A narrative review	16
MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis	16
The therapeutic potential of galectin-1 and galectin-3 in the treatment of neurodegenerative diseases	16
Pain in cervical dystonia: mechanisms, assessment and treatment	16
Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis	15
Current perspectives on galvanic vestibular stimulation in the treatment of Parkinson’s disease	15
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia	15
Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis	14
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	14
What role should spinal cord MRI take in the future of multiple sclerosis surveillance?	14
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring	14
What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group	14
Post-traumatic hydrocephalus: the Cinderella of Neurotrauma	14
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics	13
The evidence for multidisciplinary care in Parkinson’s disease	13
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis	13
The efficacy of executive function interventions in children with autism spectrum disorder: a systematic review and meta-analysis	13
Real world considerations for newly approved CGRP receptor antagonists in migraine care	12
The role of a potential biomarker in patients with migraine: review and new insights	12
Treatment of infantile spasms: why do we know so little?	12
Status epilepticus in pregnancy: a literature review and a protocol proposal	12
Outcomes measures in idiopathic intracranial hypertension	12
Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice	12
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence	12
Is it accurate to classify ALS as a neuromuscular disorder?	12
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders	12
Speech and language therapy in primary progressive aphasia: a critical review of current practice	12
Sydenham’s chorea: from pathophysiology to therapeutics	12

Current perspectives on the diagnosis and management of fatigue in multiple sclerosis	12
Recent advancements in tension-type headache: a narrative review	12
Evaluating and managing severe headache in the emergency department	12
Current perspectives on exercise training in the management of multiple sclerosis	11
Managing bipolar disorder during pregnancy and the postpartum period: a critical review of current practice	11
Current and emerging treatment modalities for spinocerebellar ataxias	11
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy	11
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion	11
Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approaches	11
Broad spectrum micronutrient formulas for the treatment of symptoms of depression, stress, and/or anxiety: a systematic review	11
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation	11
Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders	11
Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options	11
Can mindfulness-based interventions benefit people with dementia? Drawing on the evidence from a systematic review in populations with cognitive impairments	11
Updated review on the link between cortical spreading depression and headache disorders	11
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting	11
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome	10
Emerging treatments for progressive myoclonus epilepsies	10
Should we move dementia research funding from a cure to its care?	10
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	10
Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease	10
The therapeutic effect of habit reversal training for Tourette syndrome: a meta-analysis of randomized control trials	10
Developments in treating the nonmotor symptoms of stroke	10
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis	10
Current perspectives on sex differences in tension-type headache	10
Considering patient age when treating multiple sclerosis across the adult lifespan	10
Neurotechnologies as tools for cognitive rehabilitation in stroke patients	10
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis	10
What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?	10
A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders	9
Incisionless MR-guided focused ultrasound: technical considerations and current therapeutic approaches in psychiatric disorders	9
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	9
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures	9
Memory deficits in patients with major depression: yes, they are trying hard enough!	9
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis	9
Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management	9
Reading mind from the eyes in individuals with attention deficit-hyperactivity disorder (ADHD): A meta-analysis	9
Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review	9
Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress	9
A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters	9
Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry	8
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia	8
Multidisciplinary approach to degenerative cervical myelopathy	8
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials	8
Current perspectives on co-morbid depression and multiple sclerosis	8
Deep brain stimulation for treatment-resistant depression: a safe and effective option	8
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	8
A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients	8
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	8
Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review	8
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?	7
Aripiprazole for the treatment of Tourette syndrome	7
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosis	7
A reappraisal of the value of video-EEG recording in the emergency department	7
Suicidality and antiepileptic drugs in people with epilepsy: an update	7
The severity of obsessive-compulsive symptoms in Tourette syndrome and its relationship with premonitory urges: a meta-analysis	7
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review	7
Recently available and emerging therapeutic strategies for the acute and prophylactic management of cluster headache: a systematic review and expert opinion	7
Gene therapy and immunotherapy as promising strategies to combat Huntington’s disease-associated neurodegeneration: emphasis on recent updates and future perspectives	7
Non-pharmacological treatments for pediatric refractory epilepsies	7
Meniere disease subtyping: the direction of diagnosis and treatment in the future	7
Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson’s disease management in developing countries	7
Autologous hematopoietic stem-cell transplantation in neurological disorders: current approach and future directions	7
Considering hearing loss as a modifiable risk factor for dementia	7
A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodes	7
Updated perspectives on awake neurosurgery with cognitive and emotional assessment for patients with low-grade gliomas	7
Moving beyond anti-aquaporin-4 antibodies: emerging biomarkers in the spectrum of neuromyelitis optica	7
‘Dopamine agonist Phobia’ in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine	7
Diagnostic challenges in metabolic myopathies	7
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine	6
Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis	6
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper	6
Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports	6
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance	6
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice	6
Hormonal therapies in migraine management: current perspectives on patient selection and risk management	6
Exercise is medicine: a new perspective for health promotion in bipolar disorder	6
A review of magnetoencephalography use in pediatric epilepsy: an update on best practice	6
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease	6
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?	6

Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges	6
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry	6
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia	6
Deep transcranial magnetic stimulation for obsessive compulsive disorder	6
Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis	6
Acute symptomatic neonatal seizures, brain injury, and long-term outcome: The role of neuroprotective strategies	6
Lasmiditan: an additional therapeutic option for the acute treatment of migraine	6
Treatment considerations in myasthenia gravis for the pregnant patient	5
Exploring treatments for drooling in children with neurological disorders	5
Efficacy and safety of greater occipital nerve block for the treatment of cervicogenic headache: a systematic review	5
Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development	5
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy	5
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	5
Cinnarizine as an alternative recommendation for migraine prophylaxis: a narrative review	5
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	5
A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavio	5
Tumefactive demyelination: updated perspectives on diagnosis and management	5
Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes	5
Improving long-term survival in diffuse intrinsic pontine glioma	5
Fibromyalgia patients should always be screened for post-traumatic stress disorder	5
Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy	5
Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugs	5
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives	5
Gene and cell therapy and nanomedicine for the treatment of multiple sclerosis: bibliometric analysis and systematic review of clinical outcomes	5
Neuropsychological performance across symptom dimensions of obsessive-compulsive disorder: a comment on the state and critical review of the literature	5
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	5
Emerging cytoprotective peptide therapies for stroke	5
Novel therapeutic options for Dravet and Lennox-Gastaut syndrome	5
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	5
Narrative review of the multisensory integration tasks used with older adults: inclusion of multisensory integration tasks into neuropsychological assessment	5
Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations	5
The effect of transcranial magnetic stimulation on the recovery of attention and memory impairment following stroke: a systematic review and meta-analysis	5
Treating hallucinations in Parkinson’s disease	5
Considering safety and patient tolerance in the use of ketogenic diet in the management of refractory and super-refractory status epilepticus: a systematic review	5
Early recognition and diagnosis of multiple system atrophy: best practice and emerging concepts	5
Dyspnea in Parkinson’s disease: an approach to diagnosis and management	5
Cutting edge approaches to detecting brain mosaicism associated with common focal epilepsies: implications for diagnosis and potential therapies	5
An update on acute and preventive treatments for migraine in children and adolescents	5
Smoking and disability progression in multiple sclerosis	5
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	5
Developments in the mechanistic understanding and clinical application of deep brain stimulation for Parkinson’s disease	5
Objective measurement versus clinician-based assessment for Parkinson’s disease	4
Managing CLN2 disease: a treatable neurodegenerative condition among other treatable early childhood epilepsies	4
Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review	4
Postoperative pain: a review of emerging therapeutic options	4
Withdrawal seizures: possible risk factors	4
Emerging evidence for noninvasive vagus nerve stimulation for the treatment of vestibular migraine	4
Telerehabilitation in neurorehabilitation: has it passed the COVID test?	4
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication	4
Drug profile: galcanezumab for prevention of cluster headache	4
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	4
Polyamines serum levels in episodic and chronic migraine	4
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	4
Considerations when treating high-grade pediatric glioma patients with immunotherapy	4
Overcoming clinical challenges of refractory neuropathic pain	4
Do we need to reconsider the classification of vestibular migraine?	4
An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis	4
The efficacy of rehabilitation in people with Guillain-Barrè syndrome: a systematic review of randomized controlled trials	4
Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting	4
Clinical applications of exercise in Parkinson’s disease: what we need to know?	4
Antiseizure medication-induced obsessive-compulsive disorder and tic disorder: a pragmatic review	4
Developing precision treatments for epilepsy using patient and animal models	4
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury	4